Asthma Allergy Immunology

Asthma Allergy Immunology

2020, Vol 18, Num, 3     (Pages: 156-158)

Ecchymosis: An Unexpected Side Effect of Montelukast

Gokce ESER 1, Mustafa BERBER 1, Hulya ERCAN SARICOBAN 2,

1 Division of Pediatrics, Yeditepe University, Faculty of Medicine, Istanbul, Turkey
2 Division of Pediatric Allergy, Yeditepe University, Faculty of Medicine, Istanbul, Turkey

DOI: 10.21911/aai.570
Viewed: 842
Downloaded : 475

Montelukast is a leukotriene receptor antagonist that is used to treat allergy and asthma. It acts as a cysteinyl leukotriene receptor antagonist that blocks the action of leukotrienes and decreases inflammation. This agent is generally well tolerated in clinical practice. Although montelukast is generally considered as a safe drug, it can cause a few adverse drug reactions. In this case study, a rare side effect of montelukast that has been reported only twice before is presented. The importance of this case report is that the youngest patient who had ecchymosis due to the use of montelukast treatment is reported.

Keywords : Drug, ecchymosis, montelukast, treatment, allergy